{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:56:34Z","timestamp":1759341394208,"version":"3.37.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA028477"],"award-info":[{"award-number":["DA028477"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s00213-019-05411-z","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T06:02:35Z","timestamp":1575957755000},"page":"723-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The sigma receptor ligand N-phenylpropyl-N\u2032-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice"],"prefix":"10.1007","volume":"237","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-2248","authenticated-orcid":false,"given":"Melissa A.","family":"Tapia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.","family":"Sage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma I.","family":"Fullerton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica M.","family":"Judd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige C.","family":"Hildebrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Will","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Z.","family":"Lever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Lever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"5411_CR1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2017.05.035","volume":"809","author":"Y Ago","year":"2017","unstructured":"Ago Y, Hasebe S, Hiramatsu N, Hashimoto H, Takuma K, Matsuda T (2017) Psychopharmacology of combined activation of the serotonin1A and sigma1 receptors. Eur J Pharmacol 809:172\u2013177","journal-title":"Eur J Pharmacol"},{"key":"5411_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnmol.2018.00017","volume":"11","author":"D Aguinaga","year":"2018","unstructured":"Aguinaga D, Medrano M, Vega-Quiroga I, Gysling K, Canela EI, Navarro G, Franco R (2018) Cocaine Effects on Dopaminergic Transmission Depend on a Balance between Sigma-1 and Sigma-2 Receptor Expression. Front Mol Neurosci 11:17","journal-title":"Front Mol Neurosci"},{"key":"5411_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0896-6273(02)00677-3","volume":"34","author":"E Aydar","year":"2002","unstructured":"Aydar E, Palmer CP, Klyachko VA, Jackson MB (2002) The sigma receptor as a ligand-regulated auxiliary potassium channel subunit. Neuron 34:399\u2013410","journal-title":"Neuron"},{"key":"5411_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.30","volume":"12","author":"MT Bardo","year":"1998","unstructured":"Bardo MT (1998) Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 12:37\u201367","journal-title":"Crit Rev Neurobiol"},{"key":"5411_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000569","volume":"153","author":"MT Bardo","year":"2000","unstructured":"Bardo MT, Bevins RA (2000) Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology 153:31\u201343","journal-title":"Psychopharmacology"},{"key":"5411_CR6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0149-7634(94)00021-R","volume":"19","author":"MT Bardo","year":"1995","unstructured":"Bardo MT, Rowlett JK, Harris MJ (1995) Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev 19:39\u201351","journal-title":"Neurosci Biobehav Rev"},{"key":"5411_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pbb.2017.03.003","volume":"155","author":"DO Borroto-Escuela","year":"2017","unstructured":"Borroto-Escuela DO, Narvaez M, Wydra K, Pintsuk J, Pinton L, Jimenez-Beristain A, Di Palma M, Jastrzebska J, Filip M, Fuxe K (2017) Cocaine self-administration specifically increases A2AR-D2R and D2R-sigma1R heteroreceptor complexes in the rat nucleus accumbens shell. Relevance for cocaine use disorder. Pharmacol Biochem Behav 155:24\u201331","journal-title":"Pharmacol Biochem Behav"},{"key":"5411_CR8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pbb.2010.09.013","volume":"97","author":"AA Braun","year":"2011","unstructured":"Braun AA, Skelton MR, Vorhees CV, Williams MT (2011) Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents. Pharmacol Biochem Behav 97:406\u2013415","journal-title":"Pharmacol Biochem Behav"},{"key":"5411_CR9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0361-9230(93)90102-H","volume":"30","author":"DJ Calcagnetti","year":"1993","unstructured":"Calcagnetti DJ, Schechter MD (1993) Extinction of cocaine-induced place approach in rats: a validation of the \"biased\" conditioning procedure. Brain Res Bull 30:695\u2013700","journal-title":"Brain Res Bull"},{"key":"5411_CR10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2003.11.032","volume":"485","author":"S Chaki","year":"2004","unstructured":"Chaki S, Nakazato A, Kennis L, Nakamura M, Mackie C, Sugiura M, Vinken P, Ashton D, Langlois X, Steckler T (2004) Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995\/CRA0450. Eur J Pharmacol 485:145\u2013158","journal-title":"Eur J Pharmacol"},{"key":"5411_CR11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2174\/157015908787386113","volume":"6","author":"EJ Cobos","year":"2008","unstructured":"Cobos EJ, Entrena JM, Nieto FR, Cendan CM, Del Pozo E (2008) Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr Neuropharmacol 6:344\u2013366","journal-title":"Curr Neuropharmacol"},{"key":"5411_CR12","volume-title":"Practical nonparametric statistics","author":"WJ Conover","year":"1980","unstructured":"Conover WJ (1980) Practical nonparametric statistics, 2nd edn. Wiley, New York","edition":"2"},{"key":"5411_CR13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0091-3057(77)90036-3","volume":"6","author":"LL Coughenour","year":"1977","unstructured":"Coughenour LL, McLean JR, Parker RB (1977) A new device for the rapid measurement of impaired motor function in mice. Pharmacol Biochem Behav 6:351\u2013353","journal-title":"Pharmacol Biochem Behav"},{"key":"5411_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1744-9081-7-29","volume":"7","author":"AF Eisener-Dorman","year":"2011","unstructured":"Eisener-Dorman AF, Grabowski-Boase L, Tarantino LM (2011) Cocaine locomotor activation, sensitization and place preference in six inbred strains of mice. Behav Brain Funct 7:29","journal-title":"Behav Brain Funct"},{"key":"5411_CR15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0149-7634(89)80018-1","volume":"13","author":"A Ettenberg","year":"1989","unstructured":"Ettenberg A (1989) Dopamine, neuroleptics and reinforced behavior. Neurosci Biobehav Rev 13:105\u2013111","journal-title":"Neurosci Biobehav Rev"},{"key":"5411_CR16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF02244244","volume":"103","author":"A Ettenberg","year":"1991","unstructured":"Ettenberg A, Geist TD (1991) Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology 103:455\u2013461","journal-title":"Psychopharmacology"},{"key":"5411_CR17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.yhbeh.2004.04.009","volume":"46","author":"ED Festa","year":"2004","unstructured":"Festa ED, Quinones-Jenab V (2004) Gonadal hormones provide the biological basis for sex differences in behavioral responses to cocaine. Horm Behav 46:509\u2013519","journal-title":"Horm Behav"},{"key":"5411_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000322534","volume":"87","author":"M Fritz","year":"2011","unstructured":"Fritz M, Klement S, El Rawas R, Saria A, Zernig G (2011) Sigma1 receptor antagonist BD1047 enhances reversal of conditioned place preference from cocaine to social interaction. Pharmacology 87:45\u201348","journal-title":"Pharmacology"},{"key":"5411_CR19","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0968-0896(97)00093-X","volume":"5","author":"K Fujimura","year":"1997","unstructured":"Fujimura K, Matsumoto J, Niwa M, Kobayashi T, Kawashima Y, In Y, Ishida T (1997) Synthesis, structure and quantitative structure-activity relationships of sigma receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl) piperazines. Bioorg Med Chem 5:1675\u20131683","journal-title":"Bioorg Med Chem"},{"key":"5411_CR20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1196\/annals.1316.006","volume":"1025","author":"FS Hall","year":"2004","unstructured":"Hall FS, Sora I, Drgonova J, Li XF, Goeb M, Uhl GR (2004) Molecular mechanisms underlying the rewarding effects of cocaine. Ann N Y Acad Sci 1025:47\u201356","journal-title":"Ann N Y Acad Sci"},{"key":"5411_CR21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1073\/pnas.98.2.491","volume":"98","author":"T Hayashi","year":"2001","unstructured":"Hayashi T, Su TP (2001) Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci U S A 98:491\u2013496","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5411_CR22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00023210-200418050-00001","volume":"18","author":"T Hayashi","year":"2004","unstructured":"Hayashi T, Su TP (2004) Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs 18:269\u2013284","journal-title":"CNS Drugs"},{"key":"5411_CR23","first-page":"490","volume":"278","author":"CA Heidbreder","year":"1996","unstructured":"Heidbreder CA, Thompson AC, Shippenberg TS (1996) Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 278:490\u2013502","journal-title":"J Pharmacol Exp Ther"},{"key":"5411_CR24","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(01)01229-8","volume":"426","author":"B Horan","year":"2001","unstructured":"Horan B, Dewey SL, Gardner EL, Brodie JD, Ashby CR Jr (2001) The selective \u03c31 receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats. Eur J Pharmacol 426:R1","journal-title":"Eur J Pharmacol"},{"key":"5411_CR25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tips.2013.01.004","volume":"34","author":"JP Huston","year":"2013","unstructured":"Huston JP, Silva MA, Topic B, Muller CP (2013) What's conditioned in conditioned place preference? Trends Pharmacol Sci 34:162\u2013166","journal-title":"Trends Pharmacol Sci"},{"key":"5411_CR26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1146\/annurev.neuro.29.051605.113009","volume":"29","author":"SE Hyman","year":"2006","unstructured":"Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565\u2013598","journal-title":"Annu Rev Neurosci"},{"key":"5411_CR27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbr.2016.05.056","volume":"311","author":"LL Ji","year":"2016","unstructured":"Ji LL, Peng JB, Fu CH, Cao D, Li D, Tong L, Wang ZY (2016) Activation of Sigma-1 receptor ameliorates anxiety-like behavior and cognitive impairments in a rat model of post-traumatic stress disorder. Behav Brain Res 311:408\u2013415","journal-title":"Behav Brain Res"},{"key":"5411_CR28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2012.12.004","volume":"152","author":"S Kourrich","year":"2013","unstructured":"Kourrich S, Hayashi T, Chuang JY, Tsai SY, Su TP, Bonci A (2013) Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 152:236\u2013247","journal-title":"Cell"},{"key":"5411_CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1358\/mf.2007.29.5.1117557","volume":"29","author":"SK Kulkarni","year":"2007","unstructured":"Kulkarni SK, Singh K, Bishnoi M (2007) Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs. Methods Find Exp Clin Pharmacol 29:343\u2013348","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"5411_CR30","first-page":"345","volume":"275","author":"G Laviola","year":"1995","unstructured":"Laviola G, Wood RD, Kuhn C, Francis R, Spear LP (1995) Cocaine sensitization in periadolescent and adult rats. J Pharmacol Exp Ther 275:345\u2013357","journal-title":"J Pharmacol Exp Ther"},{"key":"5411_CR31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/syn.20253","volume":"59","author":"JR Lever","year":"2006","unstructured":"Lever JR, Gustafson JL, Xu R, Allmon RL, Lever SZ (2006) Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503. Synapse 59:350\u2013358","journal-title":"Synapse"},{"key":"5411_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/jpet.108.141051","volume":"327","author":"Y Liu","year":"2008","unstructured":"Liu Y, Matsumoto RR (2008) Alterations in fos-related antigen 2 and sigma1 receptor gene and protein expression are associated with the development of cocaine-induced behavioral sensitization: time course and regional distribution studies. J Pharmacol Exp Ther 327:187\u2013195","journal-title":"J Pharmacol Exp Ther"},{"key":"5411_CR33","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/sj.npp.1301323","volume":"32","author":"R Martin-Fardon","year":"2007","unstructured":"Martin-Fardon R, Maurice T, Aujla H, Bowen WD, Weiss F (2007) Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology 32:1967\u20131973","journal-title":"Neuropsychopharmacology"},{"key":"5411_CR34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","volume":"280","author":"RR Matsumoto","year":"1995","unstructured":"Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, De Costa BR (1995) Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism. Eur J Pharmacol 280:301\u2013310","journal-title":"Eur J Pharmacol"},{"key":"5411_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(03)01723-0","volume":"469","author":"RR Matsumoto","year":"2003","unstructured":"Matsumoto RR, Liu Y, Lerner M, Howard EW, Brackett DJ (2003) Sigma receptors: potential medications development target for anti-cocaine agents. Eur J Pharmacol 469:1\u201312","journal-title":"Eur J Pharmacol"},{"key":"5411_CR36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.pbb.2004.01.014","volume":"77","author":"RR Matsumoto","year":"2004","unstructured":"Matsumoto RR, Potelleret FH, Mack A, Pouw B, Zhang Y, Bowen WD (2004) Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies. Pharmacol Biochem Behav 77:775\u2013781","journal-title":"Pharmacol Biochem Behav"},{"key":"5411_CR37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pbb.2016.11.003","volume":"150-151","author":"DK Miller","year":"2016","unstructured":"Miller DK, Park ES, Lever SZ, Lever JR (2016) N-phenylpropyl-N'-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice. Pharmacol Biochem Behav 150-151:198\u2013206","journal-title":"Pharmacol Biochem Behav"},{"key":"5411_CR38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1369-1600.2012.00488.x","volume":"19","author":"T Mori","year":"2014","unstructured":"Mori T, Rahmadi M, Yoshizawa K, Itoh T, Shibasaki M, Suzuki T (2014) Inhibitory effects of SA4503 on the rewarding effects of abused drugs. Addict Biol 19:362\u2013369","journal-title":"Addict Biol"},{"key":"5411_CR39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.bmc.2007.10.037","volume":"16","author":"RI Nahas","year":"2008","unstructured":"Nahas RI, Lever JR, Lever SZ (2008) Synthesis and structure-activity relationships of N-(3-phenylpropyl)-N'-benzylpiperazines: Potent ligands for sigma1 and sigma2 receptors. Bioorg Med Chem 16:755\u2013761","journal-title":"Bioorg Med Chem"},{"key":"5411_CR40","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1073\/pnas.1008911107","volume":"107","author":"G Navarro","year":"2010","unstructured":"Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Cortes A, Casado V, Canela EI, Ortiz J, Fuxe K, Lluis C, Ferre S, Franco R (2010) Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci U S A 107:18676\u201318681","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5411_CR41","first-page":"1171","volume":"286","author":"RC Pierce","year":"1998","unstructured":"Pierce RC, Quick EA, Reeder DC, Morgan ZR, Kalivas PW (1998) Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther 286:1171\u20131176","journal-title":"J Pharmacol Exp Ther"},{"key":"5411_CR42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pbb.2010.11.016","volume":"97","author":"KR Rodvelt","year":"2011","unstructured":"Rodvelt KR, Lever SZ, Lever JR, Blount LR, Fan KH, Miller DK (2011) SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus. Pharmacol Biochem Behav 97:676\u2013682","journal-title":"Pharmacol Biochem Behav"},{"key":"5411_CR43","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/sj.npp.1300885","volume":"31","author":"P Romieu","year":"2006","unstructured":"Romieu P, Lucas M, Maurice T (2006) Sigma1 receptor ligands and related neuroactive steroids interfere with the cocaine-induced state of memory. Neuropsychopharmacology 31:1431\u20131443","journal-title":"Neuropsychopharmacology"},{"key":"5411_CR44","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1097\/00001756-200009110-00011","volume":"11","author":"P Romieu","year":"2000","unstructured":"Romieu P, Martin-Fardon R, Maurice T (2000) Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference. Neuroreport 11:2885\u20132888","journal-title":"Neuroreport"},{"key":"5411_CR45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-004-1814-x","volume":"175","author":"P Romieu","year":"2004","unstructured":"Romieu P, Meunier J, Garcia D, Zozime N, Martin-Fardon R, Bowen WD, Maurice T (2004) The sigma1 (sigma1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming. Psychopharmacology 175:154\u2013162","journal-title":"Psychopharmacology"},{"key":"5411_CR46","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0893-133X(01)00391-8","volume":"26","author":"P Romieu","year":"2002","unstructured":"Romieu P, Phan VL, Martin-Fardon R, Maurice T (2002) Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology 26:444\u2013455","journal-title":"Neuropsychopharmacology"},{"key":"5411_CR47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pbb.2013.07.006","volume":"110","author":"AS Sage","year":"2013","unstructured":"Sage AS, Oelrichs CE, Davis DC, Fan KH, Nahas RI, Lever SZ, Lever JR, Miller DK (2013a) Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice. Pharmacol Biochem Behav 110:201\u2013207","journal-title":"Pharmacol Biochem Behav"},{"key":"5411_CR48","first-page":"546314","volume":"2013","author":"AS Sage","year":"2013","unstructured":"Sage AS, Vannest SC, Fan KH, Will MJ, Lever SZ, Lever JR, Miller DK (2013b) N-Phenylpropyl-N'-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice. ISRN Pharmacol 2013:546314","journal-title":"ISRN Pharmacol"},{"key":"5411_CR49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00008877-200004000-00003","volume":"11","author":"C Sanchez","year":"2000","unstructured":"Sanchez C, Papp M (2000) The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression. Behav Pharmacol 11:117\u2013124","journal-title":"Behav Pharmacol"},{"key":"5411_CR50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02244871","volume":"116","author":"JK Shepherd","year":"1994","unstructured":"Shepherd JK, Grewal SS, Fletcher A, Bill DJ, Dourish CT (1994) Behavioural and pharmacological characterisation of the elevated \"zero-maze\" as an animal model of anxiety. Psychopharmacology 116:56\u201364","journal-title":"Psychopharmacology"},{"key":"5411_CR51","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneumeth.2010.03.026","volume":"189","author":"H Shiotsuki","year":"2010","unstructured":"Shiotsuki H, Yoshimi K, Shimo Y, Funayama M, Takamatsu Y, Ikeda K, Takahashi R, Kitazawa S, Hattori N (2010) A rotarod test for evaluation of motor skill learning. J Neurosci Methods 189:180\u2013185","journal-title":"J Neurosci Methods"},{"key":"5411_CR52","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0301-0082(98)00060-4","volume":"56","author":"TM Tzschentke","year":"1998","unstructured":"Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613\u2013672","journal-title":"Prog Neurobiol"},{"key":"5411_CR53","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0091-3057(91)90054-6","volume":"39","author":"F van Haaren","year":"1991","unstructured":"van Haaren F, Meyer ME (1991) Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol Biochem Behav 39:923\u2013927","journal-title":"Pharmacol Biochem Behav"},{"key":"5411_CR54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130000493","volume":"151","author":"LJ Vanderschuren","year":"2000","unstructured":"Vanderschuren LJ, Kalivas PW (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151:99\u2013120","journal-title":"Psychopharmacology"},{"key":"5411_CR55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","volume":"94","author":"RA Wise","year":"1987","unstructured":"Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469\u2013492","journal-title":"Psychol Rev"},{"key":"5411_CR56","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bmc.2014.11.007","volume":"23","author":"R Xu","year":"2015","unstructured":"Xu R, Lord SA, Peterson RM, Fergason-Cantrell EA, Lever JR, Lever SZ (2015) Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters. Bioorg Med Chem 23:222\u2013230","journal-title":"Bioorg Med Chem"},{"key":"5411_CR57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.pbb.2011.12.016","volume":"101","author":"YT Xu","year":"2012","unstructured":"Xu YT, Robson MJ, Szeszel-Fedorowicz W, Patel D, Rooney R, McCurdy CR, Matsumoto RR (2012) CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain. Pharmacol Biochem Behav 101:174\u2013180","journal-title":"Pharmacol Biochem Behav"},{"key":"5411_CR58","doi-asserted-by":"crossref","first-page":"235970","DOI":"10.4303\/jdar\/235970","volume":"5","author":"Y Yasui","year":"2016","unstructured":"Yasui Y, Su TP (2016) Potential Molecular Mechanisms on the Role of the Sigma-1 Receptor in the Action of Cocaine and Methamphetamine. J Drug Alcohol Res 5:235970","journal-title":"J Drug Alcohol Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05411-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05411-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05411-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T01:56:12Z","timestamp":1607478972000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05411-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["5411"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05411-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}